Rani Therapeutics, LLC — Form D
Rani Therapeutics, LLC of SAN JOSE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-09-13. The offering totals $126.5M, of which $38.7M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2017-09-13
- Form: D
- Accession: 0001644130-17-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $126.5M
- Amount sold: $38.7M
- Remaining: $87.8M
- Minimum investment: $1
- Investors: 12
- Date of first sale: 2017-08-24
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-294562
Issuer
- Name: Rani Therapeutics, LLC
- CIK: 0001644130
- Entity type: Limited Liability Company
- Jurisdiction: CALIFORNIA
- Incorporated: 2012
- Address: 2051 RINGWOOD AVENUE, SAN JOSE, CA, 95131
- Phone: 408-457-3712
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| David Pyott | Director | San Jose, CA |
| Svai Sanford | Executive Officer | San Jose, CA |
| Mir Hashim | Director | San Jose, CA |
| Mir Hashim | Executive Officer | San Jose, CA |
| Mir Imran | Director | Mountain View, CA |
| Mir Imran | Executive Officer | Mountain View, CA |
| Dennis Ausiello | Director | San Jose, CA |
| Andrew Farquharson | Director | San Jose, CA |
| Maulik Nanavaty | Director | San Jose, CA |
Other filings by this issuer (3)
More